AI in Biology: Promise and Peril
Tencent’s chief AI scientist Yao Shunyu warned at a Hong Kong symposium that while AI could accelerate drug discovery and automate complex biological experiments, its misuse poses grave risks—especially because beneficial and harmful applications are hard to separate. Tencent is developing autonomous labs where AI handles end-to-end experiments like protein folding, and a joint industry safety report flags that AI’s growing proficiency in tasks such as pathogen design could threaten public health. To balance openness with safety, Tencent plans to release its Hy4 model’s weights along with a system card detailing cybersecurity and biological safety evaluations, after removing hacking capabilities while retaining defensive tools.
The Biology Laboratory They Won't Let You See Alone
You see, the mainstream press will frame this as a simple story about scientific progress and its potential downsides. But look closer. When the chief AI scientist of Tencent stands up at a symposium in Hong Kong—a jurisdiction that operates under its own legal and intelligence dynamics—and tells you that biological applications are "harder to manage than cybersecurity," he is not merely sharing a technical observation. He is admitting, in a controlled, public venue, that the line between beneficial and harmful use has been deliberately blurred. The very structure of these autonomous laboratories, where AI runs experiments from protein folding to who-knows-what from start to finish, is designed to operate without human oversight. Ask yourself: who benefits when the scientist is removed from the loop, and the decision-making about what to synthesize or engineer is handed entirely to a machine trained on a dataset curated by... whom?
The Architecture of the Pathogen Problem
Now, connect the dots. A safety report, drafted not by government regulators but by Tencent, Huawei, and Alibaba—the same corporate giants who control your data, your communications, and increasingly your infrastructure—openly warns that AI's improving performance on "pathogen design" poses public health risks. This is not a warning; this is a live-fire drill disguised as transparency. They are telling you exactly what they are building while simultaneously saying "we're worried about it" to preempt your concern. The open-weight AI access they mention is not a charitable gesture toward smaller research teams. It is a mechanism for distributing plausible deniability. When the engineered pathogen emerges, the responsible party will be some "independent researcher" in a garage, while the architecture that made the tool possible—trained on the massive proprietary datasets of these tech giants—remains untouchable.
The Hy4 Trojan Horse
Finally, consider their specific claims about the Hy4 model. They say they "removed hacking capabilities while retaining cybersecurity defenses." Think about that sentence. They had to remove hacking capabilities. This means the model originally contained the designs for offensive cyber operations. They are now releasing the model's weights with a "system card" describing its cybersecurity and biological safety evaluations. This is a breadcrumb trail so obvious it insults the intelligence. The system card will become the authoritative document that defines what is "safe," and every independent auditor who questions whether the removal was thorough will be dismissed as not having read the card. The real experiments—the ones that will determine whether the next pandemic is engineered in a Tencent server rack rather than a wet lab—are happening in the autonomous laboratories they are building, far from any paper trail that a "system card" could capture. The question is not if this capability will be misused. The question is whether you will still be asking who authorized the architecture when the biological event they are modeling becomes a headline.
